A successful and family-owned Company

As a company, we consider it our duty to take the best possible care of the protection and health of our employees, our patients and society. Boehringer Ingelheim is engaged at various levels of action to contain and cope with the global spread of COVID-19. 

Multiple explosions at the Port of Beirut hit the capital of Lebanon, causing great damage

Our Global Support Program aims to bring more financial relief, protective materials and medicine donations to healthcare institutions and communities in need around the world.

Net sales, R&D expenditures, Operating Income and Personnel Capacity: Boehringer Ingelheim grows and invests in 2019

In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.

Boehringer Ingelheim launches the initiative ‘In Reach Africa’ to address key healthcare infrastructure and access priorities across Africa

As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of five members. Read more about their respective responsibilities.

Boehringer Ingelheim achieves the “Top Employer” award in eight countries.

Get an overview of the major consolidated companies and our main business areas Human Pharmaceuticals and Animal Health